Humoral Rejection

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2018-03-29
Clinical Trial Update: Effects of Thymoglobulin on Human B Cells
A clinical trial studying the effects of Thymoglobulin on human B cells in acute and chronic humoral rejection contexts has been withdrawn.
CLINICAL_TRIALS trial_result · 2017-09-21
Clinical Trial Update: Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation [Phase 2]
Phase 2 trial of eculizumab for antibody-mediated rejection after kidney transplant was terminated; results posted in 2017.